Fecal calprotectin in the differential diagnosis of acute intestinal infections
https://doi.org/10.22625/2072-6732-2018-10-2-117-122
Abstract
Infectious diarrhea takes a leading position in all infectious diseases worldwide. As a result of the pathogens diversity, patient-specific diagnosis and treatments are needed. Additional laboratory tests are crucial for differentiation among pathogens, as routine bacteriological and virological methods are time-consuming. One of them is fecal calprotectin.
Aim: examination of the potential role of fecal calprotectin in infectious diarrhea.
Materials and methods: the national and international medical literature sources were analyzed.
Results: the data regarding fecal calprotectins’ structure, functional activity and diagnostic value are presented.
Conclusions: the study of fecal calprotectin, as a correlative biomarker of bacterial gastroenteritis, can be helpful for clinicians with diagnostic approach to the patient.
About the Authors
E. D. Vlkova
Medical University «Prof. Dr. Paraskev Stoyanov»
Bulgaria
Varna, Bulgaria
Bulgaria
Varna, Bulgaria
M. D. Gospodinova
Medical University «Prof. Dr. Paraskev Stoyanov»
Bulgaria
Varna, Bulgaria
Bulgaria
Varna, Bulgaria
I. T. Todorov
Medical University «Prof. Dr. Paraskev Stoyanov»
Bulgaria
Varna, Bulgaria
Bulgaria
Varna, Bulgaria
References
1. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990– 2013: a systematic analysis for the Global Burden of Disease Study 2013. Vos, Theo et al. The Lancet , Volume 386 , Issue 9995 , 743 – 800
2. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990– 2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet , Volume 385 , Issue 9963 , 117 – 171
3. WHO-MCEE methods and data sources for child causes of death 2000-2015 (Global Health Estimates Technical Paper WHO/HIS/IER/GHE/2016.1. Available from: http://www.who.int/healthinfo/global_burden_disease/en/
4. Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, Rudan I, Campbell H, Cibulskis R, Li M, Mathers C, Black RE; Child Health Epidemiology Reference Group of WHO and UNICEF. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012;379(9832):2151-61.
5. Ermolenko K.D., Lobzin Y.V., Gonchar N.V. Viral gastroenteritis in children: modern concepts of epidemiology and prevention. Journal Infectology. 2015;7(3):22- 32. (In Russ.)
6. Gospodinova M. D. Health.bg – 2014. – №3. – С. 44-48. (In Bulg.)
7. Tiholova M., Nenova M., Stojcheva-Vrtigova M. Konsensus na Blgarsko druzhestvo po infekciozni bolesti 31.10.2007г. Available from: http://bsid- bg.org/index.php/consensi/acuteint-infections (In Bulg.)
8. Tihomirova O.V., Sergeeva N.V., Sirotkin A.K., Aksenov O.A., Kvetnaja A.S. Detskie infekcii. 2003. №3. – C.7-10. (In Russ.)
9. Dikov I.N. Infectious diseases: textbook – Sofia; Znanie; 2006 (In Bulg.)
10. Fagerhol MK, Dale I, Andersson T. Release and quantitation of a leucocyte derived protein (L1). Scandinavian Journal of Haematology 1980;24:393-398.
11. Fabrizia D’Angeloa, Christian Felleyb, Jean Louis Frossarda. Calprotectin in Daily Practice: Where Do We Stand in 2017? Digestion 2017;95:293–301.
12. Aguirre JD, Culotta VC. Battles with Iron: Manganese in Oxidative Stress Protection. The Journal of Biological Chemistry. 2012;287(17):13541-13548.
13. Diaz-Ochoa VE, Lam D, Lee CS, et al. Salmonella mitigates oxidative stress and thrives in the inflamed gut by evading calprotectin-mediated manganese sequestration. Cell host & microbe. 2016;19(6):814-825.
14. Kehl-Fie TE, Chitayat S, Hood MI, et al. Nutrient metal sequestration by calprotectin inhibits bacterial superoxide defense enhancing neutrophil killing of Staphylococcus aureus. Cell host & microbe. 2011;10(2):158-164.
15. Liang SC, Tan X-Y, Luxenberg DP, et al. Interleukin (IL)- 22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. The Journal of Experimental Medicine. 2006;203(10):2271-2279.
16. Lasson, Anders. Fecal calprotectin – the usefulness in special clinical situations and issues on the sampling procedure [Doctoral thesis]. University of Gothenburg. Sahlgrenska Academy. Institute of Medicine. Department of Internal Medicine; 2014. 81 p.
17. Tibble JA, Sigthorsson G, Bridger S, Fagerhol MK, Bjarnason I: Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology 2000;119:15–22.
18. Joshi S, Lewis S, Creanor S, Ayling R: Agerelated faecal calprotectin, lactoferrin and tumour M2-PK concentrations in healthy volunteers. Ann Clin Biochem 2010;47(pt 3): 259–263.
19. Shastri YM, Bergis D, Povse N, Schäfer V, Shastri S, Weindel M, Ackermann H, Stein J: Prospective multicenter study evaluating fecal calprotectin in adult acute bacterial diarrhea. Am J Med 2008;121:1099–1106.
20. Sýkora, Josef et al. Evaluation of Faecal Calprotectin as a Valuable Non- Invasive Marker in Distinguishing Gut Pathogens in Young Children with Acute Gastroenteritis. Acta Paediatrica 99.9 (2010): 1389–1395.
21. Kessaeva I.K., Kaloeva Z.D., Barycheva L.Y., Golubeva M.V. Information of fecal calprotectin in the diagnosis of acute intestinal infections in children. Fundamental research. 2015. – № 1-1: 87-91.
22. Chen, Chien-Chang; Huang, Jing-Long; Chang, Chee-Jen; Kong, Man-Shan; Fecal Calprotectin As A Correlative Marker In Clinical Severity of Infectious Diarrhea And Usefulness In Evaluating Bacterial or Viral Pathogens In Children. Journal of Pediatric Gastroenterology and Nutrition: November 2012 – Volume 55 – Issue 5 – p 541–547
23. Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, et al.; Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015; 372(9):825–834.
24. Debast, S.B. et al.; European Society of Clinical Microbiology and Infectious Diseases: Update of the Treatment Guidance Document for Clostridium difficile Infection; Clinical Microbiology and Infection , Volume 20 , 1 – 26.
25. Kim, Jieun et al.; Fecal Calprotectin Level Reflects the Severity of Clostridium Difficile Infection; Annals of Laboratory Medicine 37.1 (2017): 53–57.
26. He M, Miyajima F, Roberts P, et al. Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nature genetics. 2013;45(1):109-113.
27. Peretz A, Tkhawkho L, Pastukh N, Brodsky D, Halevi CN, Nitzan O. Correlation between fecal calprotectin levels, disease severity and the hypervirulent ribotype 027 strain in patients with Clostridium difficile infection. BMC Infectious Diseases. 2016;16:309.
Review
For citations:
Vlkova E.D., Gospodinova M.D., Todorov I.T. Fecal calprotectin in the differential diagnosis of acute intestinal infections. Journal Infectology. 2018;10(2):117-122. (In Russ.) https://doi.org/10.22625/2072-6732-2018-10-2-117-122
Views:
2062
.png)
.png)
Email this article 